Evaluating out-of-field doses during radiotherapy of paediatric brain tumours using lead shielding and flattening-filter free beams.
Paediatric radiotherapy comes at the expense of increased risk of late effects due to out-of-field dose caused not only by the treatment itself but also by image guidance. This study examined how the out-of-field dose to selected radiosensitive organs was affected by applying a 1 mm lead shielding during delivery of volumetric-modulated arc therapy (VMAT) for paediatric brain cancer. The study also investigated how the out-of-field dose to the same organs was affected by the use of flattening-filter free (FFF) beams. Out-of-field doses to the thyroid, breast and testes were measured using thermoluminescence dosimeters inserted in two anthropomorphic phantoms equivalent to a 1-year and 5-year old child. Coplanar VMAT plans were prepared for 6 MV and 6 MV FFF photon beams and delivered using a Varian TrueBeam linear accelerator, with and without lead shielding applied to the phantoms. The measured out-of-field doses were as large as 200,9 cGy for the whole treatment, with associated secondary cancer risk being as large as 1,1%. Shielding of the phantoms was found to decrease the out-of-field dose by up to 24%. The use of 6 MV FFF beams yielded a decrease in the dose to the testes by 21-42% compared to 6 MV, while in one case increasing the dose to the thyroid by 18%. The observation that only doses to organs distant to the primary irradiated volume were significantly decreased for FFF can be explained by an increase in internal scatter caused by the softer energy spectrum of the Varian FFF beam.